Literature DB >> 24452111

Trends in the incidence and mortality of coronary heart disease in asian pacific region: the Singapore experience.

Chin Meng Khoo1, E Shyong Tai.   

Abstract

The rates of coronary heart disease are lower in Asia than in developed countries. Singapore has undergone rapid urbanization over the past several decades. In the several decades between the 1960s and 1980s, a rapid increase in the rates of ischemic heart disease was observed, to the extent that Singapore exhibits one of the highest rates of mortality from cardiovascular disease in the Asia-Pacific region, higher even than the rates in North America. Rates of cardiovascular disease have now stabilized, and are declining. This is, a pattern that has been observed in many developed countries. Increased life expectancy has resulted in an epidemiologic transition that has seen chronic non-communicable diseases replace malnutrition and infections as the major causes of mortality. At the same time, there have been changes in nutrient intake and physical activity as well as rapid increases in the levels of several cardiovascular risk factors including obesity, hypertension, hyperlipidemia, diabetes mellitus and systemic inflammation. Furthermore, when present, there is a lack of awareness and sub-optimal treatment of these risk factors. In addition to the changes in environmental exposures related to socio-economic development, it does appear that specific populations are particularly prone to the development of cardiovascular disease and its risk factors. In particular, Asian Indians experience a high rate of coronary heart disease and diabetes mellitus. Emerging data suggests that Chinese may be particularly prone to the adverse effects of obesity in relation to insulin resistance and inflammation. A concerted effort to change lifestyles to prevent the development of coronary heart disease risk factors, and to improve awareness and treatment of risk factors when then develop, is required to halt the epidemic of coronary heart disease that is occurring in Asia.

Entities:  

Mesh:

Year:  2014        PMID: 24452111     DOI: 10.5551/jat.21_sup.1-s2

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  15 in total

1.  Impact of daily lifestyle on coronary heart disease.

Authors:  Yan-Fang Wan; Xiao-Li Ma; Chen Yuan; Ling Fei; Jing Yang; Jun Zhang
Journal:  Exp Ther Med       Date:  2015-07-17       Impact factor: 2.447

2.  Main active constituent identification in Guanxinjing capsule, a traditional Chinese medicine, for the treatment of coronary heart disease complicated with depression.

Authors:  Yan-Qiong Zhang; Qiu-Yan Guo; Qiu-Yue Li; Wei-Qiong Ren; Shi-Huan Tang; Song-Song Wang; Ri-Xin Liang; De-Feng Li; Yi Zhang; Hai-Yu Xu; Hong-Jun Yang
Journal:  Acta Pharmacol Sin       Date:  2017-08-31       Impact factor: 6.150

3.  High-sensitivity troponin T and long-term adverse cardiac events among patients presenting with suspected acute coronary syndrome in Singapore.

Authors:  Ziwei Lin; Swee Han Lim; Siang Jin Terrance Chua; E Shyong Tai; Yiong Huak Chan; Arthur Mark Richards
Journal:  Singapore Med J       Date:  2019-02-18       Impact factor: 1.858

4.  Cholesterol goal achievement and lipid-lowering therapy in patients with stable or acute coronary heart disease in Singapore: results from the Dyslipidemia International Study II.

Authors:  Kian-Keong Poh; Chee Tang Chin; Khim Leng Tong; Julian Ko Beng Tan; Jee Seong Lim; Weixuan Yu; Martin Horack; Ami Vyas; Dominik Lautsch; Baishali Ambegaonkar; Philippe Brudi; Anselm K Gitt
Journal:  Singapore Med J       Date:  2019-02-18       Impact factor: 1.858

Review 5.  Diversity of and initiatives for hypertension management in Asia-Why we need the HOPE Asia Network.

Authors:  Kazuomi Kario; Yook-Chin Chia; Apichard Sukonthasarn; Yuda Turana; Jinho Shin; Chen-Huan Chen; Peera Buranakitjaroen; Jennifer Nailes; Satoshi Hoshide; Saulat Siddique; Jorge Sison; Arieska Ann Soenarta; Guru Prasad Sogunuru; Jam Chin Tay; Boon Wee Teo; Yu-Qing Zhang; Sungha Park; Huynh Van Minh; Naoko Tomitani; Tomoyuki Kabutoya; Narsingh Verma; Tzung-Dau Wang; Ji-Guang Wang
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-11-26       Impact factor: 3.738

6.  Prevalence and determinants of hypertension in Myanmar - a nationwide cross-sectional study.

Authors:  Marius B Bjertness; Aung Soe Htet; Haakon E Meyer; Maung Maung Than Htike; Ko Ko Zaw; Win Myint Oo; Tint Swe Latt; Lhamo Y Sherpa; Espen Bjertness
Journal:  BMC Public Health       Date:  2016-07-18       Impact factor: 3.295

7.  Impact of Community-Based Cardiac Rehabilitation on Clinical Parameters of Patients with Cardiovascular Diseases.

Authors:  Kheng Yong Ong; Elise Yap; Yvonne May Fen Chia; Hung Yong Tay; Peter Ting; Sui Yung Chan; Yu Heng Kwan
Journal:  ASEAN Heart J       Date:  2016-10-13

8.  Abnormally expressed miR-23b in Chinese Mongolian at high cardiovascular risk may contribute to monocyte/macrophage inflammatory reaction in atherosclerosis.

Authors:  Li-Ping He; Xing-Sheng Zhao; Le-Ping He
Journal:  Biosci Rep       Date:  2018-11-15       Impact factor: 3.840

9.  Investigating the effect of lncRNA HOTAIR on apoptosis induced by myocardial ischemia-reperfusion injury.

Authors:  Jijing Fang; Weihong Zheng; Pengfei Hu; Jiale Wu
Journal:  Mol Med Rep       Date:  2021-01-05       Impact factor: 2.952

10.  Trends in Incidence and Case Fatality Rates of Heart Disease and Its Subtypes in Korea, 2006-2015.

Authors:  Su Ra Seo; Shin Yi Jang; Sung-Il Cho
Journal:  Int J Environ Res Public Health       Date:  2020-11-15       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.